Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Senator investigating plan to limit Avastin distribution

Sen. Herb Kohl (D-Wis.) said on Wednesday he is investigating plans by Genentech (DNA) to limit the availability of Avastin bevacizumab to compounding pharmacies, which compound

Read the full 261 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE